Dorui Pharmaceuticals: Announcement on Relinquishing Priority Transfer Rights for Holding Subsidiaries and Increasing Capital and Related Transactions with Subsidiaries

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.